Literature DB >> 6858902

Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease.

J Samuel, M Oliveira, R R Correa De Araujo, M A Navarro, G Muccillo.   

Abstract

A retrospective study of Chagas' heart disease was carried out by a review of 1,345 autopsy reports, with special reference to cardiac thrombus and thromboembolic phenomena. The incidence of cardiac thrombus was higher in cases of heart failure (36%) than in cases of sudden death (15%), higher in heavier hearts, and unrelated to age or sex. The left- and right-sided cardiac chambers were equally affected by thrombus. Endocarditis and blood stasis were considered important factors in the pathogenesis of cardiac thrombus. Thromboembolic phenomena were more common in the systemic circulation but caused relatively more deaths by pulmonary embolism. Fourteen percent of patients with thromboembolic phenomena died from them. Patients with multiple thromboembolic phenomena had a higher risk of death from embolism. Cardiac thrombosis or thromboembolic phenomena, or both, were present in 44% of the cases studied. Prophylactic measures should be taken for these important complications of Chagas' heart disease.

Entities:  

Mesh:

Year:  1983        PMID: 6858902     DOI: 10.1016/0002-9149(83)90085-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

Review 1.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas' disease.

Authors:  S A Laucella; E L Segura; A Riarte; E S Sosa
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  Chagas Heart Failure in Patients from Latin America.

Authors:  Reinaldo B Bestetti
Journal:  Card Fail Rev       Date:  2016-11

4.  Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.

Authors:  Juan C Engel; Kenny K H Ang; Steven Chen; Michelle R Arkin; James H McKerrow; Patricia S Doyle
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

Review 5.  Neurologic manifestations of Chagas disease.

Authors:  Marco Oliveira Py
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

Review 6.  Chagas' heart disease.

Authors:  A Rassi; A Rassi; W C Little
Journal:  Clin Cardiol       Date:  2000-12       Impact factor: 2.882

7.  Confirmation of Chagas' cardiomyopathy following heart transplantation.

Authors:  Binh An P Phan; Michael A Laflamme; April Stempien-Otero; Ajit P Limaye; Frederick S Buckner; Wayne C Levy
Journal:  Heart Vessels       Date:  2006-09-29       Impact factor: 2.037

Review 8.  Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms.

Authors:  Marcos A Rossi; Herbert B Tanowitz; Lygia M Malvestio; Mara R Celes; Erica C Campos; Valdecir Blefari; Cibele M Prado
Journal:  PLoS Negl Trop Dis       Date:  2010-08-31

Review 9.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

Review 10.  Differential regional immune response in Chagas disease.

Authors:  Juliana de Meis; Alexandre Morrot; Désio Aurélio Farias-de-Oliveira; Déa Maria Serra Villa-Verde; Wilson Savino
Journal:  PLoS Negl Trop Dis       Date:  2009-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.